Satisfaction and adherence to pharmacological treatment for glycemic control in adults.

Abstract

Introduction: The management of Type 2 Diabetes should be based on a person-centered approach to ensure the appropriate selection of pharmacological treatment. Satisfaction with pharmacological treatment is a patient-reported assessment measure that evaluates the treatment process and related factors, which may enhance adherence and glycemic control.

Objective: To determine the strength of association between satisfaction with pharmacological treatment and adherence for glycemic control in adults with Type 2 Diabetes.

Materials and methods: A cross-sectional predictive study with model testing was conducted. A total of 146 participants with Type 2 Diabetes were enrolled using snowball sampling. The Diabetes Treatment Satisfaction Questionnaire (DTSQ), the Morisky Medication Adherence Scale (MMAS-4), and a sociodemographic and clinical data form were administered, and glycated hemoglobin level was measured. Associations were estimated using multiple linear regression.

Results: Adherence to pharmacological treatment only predicted glucose control. The difference in glycated hemoglobin between adherent and non-adherent individuals was 0.22 lower in adherent individuals (β = -0.22, F = 2.95, p = 0.001).

Discussion: The results differ from other studies that have reported subsequent changes in glycated hemoglobin associated with treatment satisfaction.

Conclusion: Adherence to pharmacological treatment influences glycemic control. It is essential for healthcare professionals to consider this evidence for decision- making and in the design, implementation, and/or reinforcement of educational interventions.